Cesium carbonate → 1-(2-(1-hydroxy-2-methylpropan-2-yloxy)-5-(4-((7R,8aS)-octahydro-5,5-dimethylindolizin-7-ylamino)-5-fluoropyrimidin-2-ylamino)-4-fluorophenyl)-4-methyl-1H-tetrazol-5(4H)-one

HRID 633395Notes

Reaction equation

HRID 633395 reaction equation
Cl.Cl[C:3]1[N:8]=[C:7]([NH:9][C@@H:10]2[CH2:18][C@H:17]3[N:13]([CH2:14][CH2:15][CH2:16]3)[C:12]([CH3:20])([CH3:19])[CH2:11]2)[C:6]([F:21])=[CH:5][N:4]=1.[NH2:22][C:23]1[C:24]([F:42])=[CH:25][C:26]([O:36][C:37]([CH3:41])([CH3:40])[CH2:38][OH:39])=[C:27]([N:29]2[C:33](=[O:34])[N:32]([CH3:35])[N:31]=[N:30]2)[CH:28]=1.C1C=CC(P(C2C(C3C(P(C4C=CC=CC=4)C4C=CC=CC=4)=CC=C4C=3C=CC=C4)=C3C(C=CC=C3)=CC=2)C2C=CC=CC=2)=CC=1.C([O-])([O-])=O.[Cs+].[Cs+]>CC([O-])=O.CC([O-])=O.[Pd+2].O1CCOCC1>[NH3:4].[CH3:33][OH:34].[OH:39][CH2:38][C:37]([CH3:41])([O:36][C:26]1[CH:25]=[C:24]([F:42])[C:23]([NH:22][C:3]2[N:8]=[C:7]([NH:9][C@@H:10]3[CH2:18][C@H:17]4[N:13]([CH2:14][CH2:15][CH2:16]4)[C:12]([CH3:20])([CH3:19])[CH2:11]3)[C:6]([F:21])=[CH:5][N:4]=2)=[CH:28][C:27]=1[N:29]1[C:33](=[O:34])[N:32]([CH3:35])[N:31]=[N:30]1)[CH3:40]

Participants

8

Conditions

Temperature
120 °C

Procedure

To a microwave vial, was added (7R,8aS)-N-(2-chloro-5-fluoropyrimidin-4-yl)-octahydro-5,5-dimethylindolizin-7-amine hydrochloride (100 mg, 0.298 mmol, 1.00 equiv), 1-(5-amino-4-fluoro-2-(1-hydroxy-2-methylpropan-2-yloxy)phenyl)-4-methyl-1H-tetrazol-5(4H)-one (133 mg, 0.447 mmol, 1.50 equiv), rac-BINAP (38 mg, 0.0597 mmol, 0.200 equiv), Cs2CO3 (292 mg, 0.895 mmol, 3.00 equiv), Pd(OAc)2 (7 mg, 0.0298 mmol, 0.100 equiv), and dioxane (3 mL). The microwave vial was capped and sonicated under vacuum for 5 min. The reaction mixture was heated in the microwave at 120° C. for 3 h. The cooled reaction mixture was filtered using a pad of celite and rinsed with dioxane, and the filtrate was concentrated. The crude product was purified by flash chromatography and eluted with DCM:2M NH3/MeOH=100:0 to 95:5 using 1% 2M NH3/MeOH increments to provide 1-(2-(1-hydroxy-2-methylpropan-2-yloxy)-5-(4-((7R,8aS)-octahydro-5,5-dimethylindolizin-7-ylamino)-5-fluoropyrimidin-2-ylamino)-4-fluorophenyl)-4-methyl-1H-tetrazol-5(4H)-one (compound 85) (85 mg, 51%) as a solid.

Workup

  1. customThe microwave vial was capped
  2. customsonicated under vacuum for 5 min
  3. customThe cooled reaction mixture
  4. filtrationwas filtered
  5. washrinsed with dioxane
  6. concentrationthe filtrate was concentrated
  7. customThe crude product was purified by flash chromatography
  8. washeluted with DCM

Sources & evidence

ORD record
ord-44c60660342e4d49a1d9d5b92884ebe2
Source dataset
uspto-grants-2016_04
Patent number
US09321763B2

Reaction notes

Loading…